Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Morano, Raúl
66  Ergebnisse:
Personensuche X
?
1

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:

Moreau, Philippe ; van de Donk, Niels W.C.J. ; Delforge, Michel...
HemaSphere.  7 (2023)  S3 - p. e690758f , 2023
Link: https://doi.org/10.1097/..
 
?
2

Comparative Efficacy of Teclistamab Versus Current Treatmen..:

Moreau, Philippe ; van de Donk, Niels W. C. J. ; Delforge, Michel...
Advances in Therapy.  40 (2023)  5 - p. 2412-2425 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Comparative Effectiveness of Teclistamab Versus Real-World ..:

Moreau, Philippe ; Mateos, María-Victoria ; Gonzalez Garcia, Maria Esther...
Advances in Therapy.  41 (2023)  2 - p. 696-715 , 2023
Link: https://doi.org/10.1007/..
 
?
4

P-294 Comparative effectiveness of teclistamab vs real-worl..:

Mateos, Maria-Victoria ; van de Donk, Niels ; Delforge, Michel...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S199 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Patient Preferences for Attributes of Type 2 Diabetes Melli..:

Mansfield, Carol ; Sikirica, Mirko V. ; Pugh, Amy...
Diabetes Therapy.  8 (2017)  6 - p. 1365-1378 , 2017
Link: https://doi.org/10.1007/..
 
?
6

Consumo de recursos sanitarios y costes asociados al inicio..:

Sicras-Mainar, Antoni ; Navarro-Artieda, Ruth ; Morano, Raúl.
Endocrinología y Nutrición.  63 (2016)  10 - p. 527-535 , 2016
Link: https://doi.org/10.1016/..
 
?
7

Use of healthcare resources and costs associated to the sta..:

Sicras-Mainar, Antoni ; Navarro-Artieda, Ruth ; Morano, Raúl.
Endocrinología y Nutrición (English Edition).  63 (2016)  10 - p. 527-535 , 2016
Link: https://doi.org/10.1016/..
 
?
8

Análisis de coste-efectividad de la vacunación antineumocóc..:

Morano, Raúl ; Pérez, Ferrán ; Brosa, Max.
Gaceta Sanitaria.  25 (2011)  4 - p. 267-273 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Cost–effectiveness analysis of quadrivalent influenza vacci..:

García, Amos ; Ortiz de Lejarazu, Raúl ; Reina, Jordi...
Human Vaccines & Immunotherapeutics.  12 (2016)  9 - p. 2269-2277 , 2016
Link: https://doi.org/10.1080/..
 
?
10

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:

Moreau, Philippe ; van de Donk, Niels W.C.J ; Delforge, Michel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431245/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
11

Comparative Efficacy of Teclistamab Versus Current Treatmen..:

Moreau, Philippe ; van de Donk, Niels W. C. J ; Delforge, Michel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129954/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
12

Patient Preferences for Attributes of Type 2 Diabetes Melli..:

Mansfield, Carol ; Sikirica, Mirko V ; Pugh, Amy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688991/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
13

P979: PATIENT-REPORTED OUTCOMES FOR TECLISTAMAB VERSUS REAL..:

Philippe Moreau ; Niels W.C.J. van de Donk ; Michel Delforge...
http://journals.lww.com/10.1097/01.HS9.0000970820.69075.8f.  , 2023
Link: https://doi.org/10.1097/..
 
?
14

Análisis de coste-efectividad de la vacunación antineumocóc..:

Raúl Morano ; Ferrán Pérez ; Max Brosa.
http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-91112011000400002.  , 2011
Link: https://doaj.org/article..
 
?
15

El asentamiento layetano del Ibérico Pleno idfentificado en..:

Balsera Moraño, Raúl ; Coll Riera, Joan-Manuel ; Roig Buxó, Jordi
http://www.raco.cat/index.php/RAP/article/view/251814.  , 2012
Link: http://hdl.handle.net/10..
 
1-15